Physician profile
Jose M Cusco
NPI 1104884352
$669.58
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $127 · 2023: $467 · 2024: $75.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $542.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $165.05 | 2022-2024 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $123.92 | 2023-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbvie INC. | $74.56 | 2023 | Ubrelvy, Linzess, Viberzi |
| Abbott Laboratories | $47.98 | 2023-2024 | Freestyle Libre |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.31 | 2022-2023 | Jardiance |
| Pfizer INC. | $33.76 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $32.16 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $28.19 | 2023 | Farxiga |
| Exact Sciences Corporation | $23.40 | 2023 | Cologuard Collection Kit |
| Inspire Medical Systems, INC. | $19.29 | 2023 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $17.91 | 2023 | |
| Impel Pharmaceuticals INC. | $16.21 | 2022 | |
| Merck Sharp & Dohme LLC | $15.11 | 2022 | |
| Novo Nordisk INC | $14.86 | 2023 | Ozempic, Rybelsus |
| Esperion Therapeutics, INC. | $13.87 | 2023 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Cusco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.